Literature DB >> 4332892

[Long-term recording of cerebral, muscular and ocular electric activities in mice].

J L Valatx.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 4332892

Source DB:  PubMed          Journal:  C R Seances Soc Biol Fil        ISSN: 0037-9026


× No keyword cloud information.
  5 in total

1.  Effects of GF-015535-00, a novel α1 GABA A receptor ligand, on the sleep-wake cycle in mice, with reference to zolpidem.

Authors:  Christelle Anaclet; Mei Zhang; Chunmei Zhao; Colette Buda; Laurent Seugnet; Jian-Sheng Lin
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

2.  Paradoxical sleep and avoidance learning of Swiss white mice after early undernutrition by raising in large litters.

Authors:  P D Leathwood; M S Busch; C D Berent; J L Valatx
Journal:  Experientia       Date:  1974-12-15

3.  Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models.

Authors:  Christelle Anaclet; Régis Parmentier; Koliane Ouk; Gérard Guidon; Colette Buda; Jean-Pierre Sastre; Hidéo Akaoka; Olga A Sergeeva; Masashi Yanagisawa; Hiroshi Ohtsu; Patricia Franco; Helmut L Haas; Jian-Sheng Lin
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

4.  Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice.

Authors:  Elise Gondard; Christelle Anaclet; Hidéo Akaoka; Rui-Xian Guo; Mei Zhang; Colette Buda; Patricia Franco; Hidehito Kotani; Jian-Sheng Lin
Journal:  Neuropsychopharmacology       Date:  2013-01-02       Impact factor: 7.853

5.  Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.

Authors:  R X Guo; C Anaclet; J C Roberts; R Parmentier; M Zhang; G Guidon; C Buda; J P Sastre; J Q Feng; P Franco; S H Brown; N Upton; A D Medhurst; J S Lin
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.